Skip to main content
Premium Trial:

Request an Annual Quote

Blueprint Initiative Receives $21.3M in Funding for Public Biomolecular Interaction Database

NEW YORK, June 20 - The Blueprint Initiative said today that it has secured CA$29 million ($21.3 million) in public and private funding to expand the Biomolecular Interaction Network Database, BIND.

 

The funding comes from Genome Canada, the Ontario Government's Research and Development Challenge Fund, the Canadian Institutes of Health Research, Sun Microsystems, MDS Proteomics, and Foundry Networks. It is contingent on certain milestones and will go towards software development, database curation, computer hardware, and networking.

 

Blueprint, led by Christopher Hogue at the Samuel Lunenfeld Research Institute in Toronto, currently has a staff of 59 - including 12 database curators and 29 software developers - and is slated to grow to 77 by the year 2005. Its scientific advisory group will be announced in the next few weeks.

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.